drugset / Trial / NCT01914913

Clinical Study to Evaluate Safety and Efficacy of BMMNC in Retinitis Pigmentosa

NCT01914913

Phase 1/2 Unknown 15 enrolled Chaitanya Hospital, Pune
NaSingle-groupOpen-labelTreatment

Summary

Retinitis pigmentosa is an eye disease in which there is damage to the retina. The retina is the layer of tissue at the back of the inner eye that converts light images to nerve signals and sends them to the brain.Autologous Bone Marrow derived Mono Nuclear Stem Cell (BMMNCs) is used for this condition .

Timeline

Start
2014-09
Primary completion
2016-11
Completion
2016-11

Drugs

EvaluationDrugModalityDoseRoute
Subject autologous bone marrow mononuclear cells Cell therapy

Indications